Inflammation, dyslipidaemia, diabetes and PPARs: pharmacological interest of dual PPARα and PPARγ agonists

Item

http://www.wikidata.org/entity/Q57244260

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2004

@uk

name

Inflammation, dyslipidaemia, d ...... dual PPARα and PPARγ agonists

@en

Inflammation, dyslipidaemia, d ...... dual PPARα and PPARγ agonists

@nl

type

Item

label

Inflammation, dyslipidaemia, d ...... dual PPARα and PPARγ agonists

@en

Inflammation, dyslipidaemia, d ...... dual PPARα and PPARγ agonists

@nl

prefLabel

Inflammation, dyslipidaemia, d ...... dual PPARα and PPARγ agonists

@en

Inflammation, dyslipidaemia, d ...... dual PPARα and PPARγ agonists

@nl

P1476

Inflammation, dyslipidaemia, d ...... dual PPARα and PPARγ agonists

@en

P2093

J.-C. Fruchart

http://www.w3.org/2001/XMLSchema#string

P. Gervois

http://www.w3.org/2001/XMLSchema#string

P2860

Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease

Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs

PPARalpha agonists inhibit tissue factor expression in human monocytes and macrophages.

PPARalpha activators inhibit tissue factor expression and activity in human monocytes.

Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells.

Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells.

Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction.

PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells.

Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway.

PPARalpha /gamma ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly.

P304

22-29

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1368-504X.2004.00376.X

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Bart Staels

P577

2004-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P921

inflammation

Farmakologi

dyslipidemias